Positive six-month results from Intact Vascular’s TOBA-BTK (Tack Optimised Balloon Angioplasty—Below-the-Knee) clinical study have been reported at LINC 2016. The data were presented by principal investigator, Marianne Brodman, head of the Clinical Division of Angiology, at Medical University of Graz in Austria.
CE mark approval has been granted to Biotronik for smaller diameters of the Passeo-18 Lux drug-coated balloon (DCB). The new sizes—2mm and 2.5mm—are designed to facilitate DCB treatment of below-the-knee arteries.
Contego Medical presented positive post-market registry data for the Paladin carotid post-dilation balloon with Integrated Embolic Protection Technology at the Leipzig Interventional Course (LINC) 2016, in Leipzig, Germany.
Vascular Solutions has announced the US launch of its enhanced line of VSI Radial introducer sheaths for use in the introduction of guidewires and catheters into veins and arteries. The VSI Radial introducer sheaths are specifically designed for patients undergoing transradial catheterisation procedures, one of the fastest-growing practices in the field of interventional cardiology in the USA.
A single-centre, retrospective study published online in December 2015 in the Journal of Vascular and Interventional Radiology (JVIR), set out to review the safety and feasibility of using transradial access for non-coronary interventions.
A new analysis of the MORE data on 606 mCRC patients treated with SIR-Spheres Y-90 resin microspheres at 11 US medical centres, published late last year in Clinical Colorectal Cancer, confirms that patient age is not a barrier to appropriate treatment with the product, Sirtex has reported.
The systematic review of administrative dataset registries, published in the January 2016 issue of the European Journal of Vascular and Endovascular Surgery (EJVES), has further concluded that stroke/death rates after carotid stenting often exceed accepted American Heart Association (AHA) thresholds. Based on this study, there was also no evidence of a sustained decline, over time, in the procedural risk after carotid stenting.
The Paladin carotid post-dilation balloon (Contego Medical) is to be commercialised in Europe. This device, according to a press release, is the first angioplasty balloon with Integrated Embolic Protection (IEP) technology for patients undergoing carotid stenting procedures.
Medtronic is to launch the OsteoCool radiofrequency ablation system for surgeons who treat patients with painful spinal metastases. The system has been granted US Food and Drug Administration (FDA) 510(k) marketing clearance.
The first US implant of the Gore Excluder thoracoabdominal branch endoprosthesis has taken place during a clinical study of the treatment of aortic aneurysms involving the visceral branch vessels.
The IN.PACT Admiral drug-eluting balloon (DEB) has been granted CE mark for arteriovenous (AV) access to help maintain haemodialysis access in patients with end-stage renal disease, according to a Medtronic press release.
Vivasure Medical has been granted CE mark approval for its fully bioabsorbable percutaneous vascular closure device for large-bore femoral arteriotomies. According to Vivasure, this is the world’s first approved bioabsorbable, sutureless and fully synthetic option to close large arteriotomies, which result from percutaneous transcatheter procedures.
Early research on a simple method to produce radiopaque drug-eluting microspheres that can be incorporated into the current clinical transcatheter arterial chemoembolization workflow has also been reported.
Forge Medical has announced receiving 510(k) clearance from the US FDA for expanded indications of the device to include pedal and tibial haemostasis. The VasoStat was previously cleared for radial artery and dialysis access haemostasis.
Penumbra’s POD (Penumbra Occlusion Device) packing coil for the embolization of peripheral vessels and aneurysms adds to its growing peripheral vascular business, which includes the Indigo mechanical thrombectomy system, POD and Ruby embolization coil.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos